Indicators

Markets:

News

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 7 Next >

The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week

January 02, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021

December 14, 2021

Where Ionis Pharmaceuticals Stands With Analysts

December 14, 2021

Jim Cramer Shares His Thoughts On Canadian Pacific Railway, Royalty Pharma And More

December 10, 2021

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré

December 07, 2021

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

December 07, 2021

Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding Disorder

December 07, 2021

These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs

November 29, 2021

Pfizer Posts Vupanorsen Data From Mid-Stage Cardiovascular Disease Trial

November 24, 2021

Barron's Most Recent Picks And Pans: General Electric, Pfizer, Walt Disney And More

November 13, 2021

Ionis Pharmaceuticals, inc (IONS) Q3 2021 Earnings Call Transcript

November 04, 2021

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering

November 03, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

Why Ionis Pharmaceuticals Stock Is Down 13% This Week

October 22, 2021

46 Biggest Movers From Yesterday

October 19, 2021

34 Stocks Moving In Monday's Mid-Day Session

October 18, 2021

Biogen's Antisense Candidate Flunks In Late-Stage Neurodegenerative Disorder Trial

October 18, 2021

3 Stocks to Consider if the October Stock Market Sell-Off Worsens

October 17, 2021

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

October 01, 2021

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

September 30, 2021

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

3 Biotech Stocks With Huge Catalysts This Fall

September 29, 2021

PTC Therapeutics' Waylivra Scores Approval In Brazil For Genetic Disorder

August 24, 2021

My 2019 Report Card: Up 319%

August 15, 2021

Ionis Pharmaceuticals, inc (IONS) Q2 2021 Earnings Call Transcript

August 04, 2021

7 F-Rated Stocks to Avoid for the Rest of 2021

August 02, 2021

After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate

July 27, 2021

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

July 25, 2021

Why Is Novo Nordisk Buying a Rare-Disease Candidate?

July 24, 2021

5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021

July 23, 2021

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.